LATEST
Our vision is grounded in the profound belief that healthcare should be as unique as the individuals it serves. In a world that’s increasingly interconnected and diverse, EAPM is dedicated to spearheading a new era in healthcare — one where precision and personalization redefine the standards of prevention and treatment strategies. Join us in exploring the forefront of medical innovation, where our commitment to individualized care is not just a goal but a revolution. Welcome to a future where healthcare truly fits you.
This interactive map visualises the current state of genomic data integration and molecular diagnostics implementation across selected European countries. It reflects findings from EAPM’s national factsheets, assessing the readiness and challenges in adopting Next-Generation Sequencing (NGS) and health data governance to support personalised cancer care.
Countries are highlighted based on their overall level of maturity in:
This classification provides a snapshot of progress and key barriers, supporting policymakers, clinicians, and stakeholders in identifying priority areas for action and collaboration.
Legend:
🟢 Advanced Integration
Countries with mature data infrastructure, routine NGS use, established governance, and existing reimbursement mechanisms.
🟡 Developing Capacity
Countries with established infrastructure and some NGS application but facing challenges in reimbursement, workforce capacity, or standardisation.
🟠 Emerging Efforts
Countries building infrastructure and initial data integration, but with significant needs in governance, workforce, and diagnostics access.
NEWS
Be informed and stay informed on all
news, events and publication updated.
The multi-stakeholder nature of the Alliance allows it to act as a one- shop for stakeholders in personalised medicine and personalised healthcare.
NEWS
Be informed and stay informed on all
news, events and publication updated.
EVENTS
Be informed and stay informed on all
news, events and publication updated.
Dublin, 2 October 2026 — The European Alliance for Personalised Medicine will convene a high-level conference in Dublin on 2 October 2026, bringing together policymakers, patient representatives, clinicians, researchers, regulators,
The European Alliance for Personalised Medicine will convene a dedicated ESMO session on “Personalised Oncology Across Health Systems: From Molecular Insight to Measurable Access” on Friday, 23 October 2026. The
The European Alliance for Personalised Medicine (EAPM) participated in the Kick-Off Meeting of the Joint Action on Personalised Cancer Medicine (JA PCM) in Brussels, as part of its engagement within
On 17–18 October 2025 in Berlin, the European Alliance for Personalised Medicine (EAPM) convened two key events aimed at accelerating the practical implementation of precision oncology across Europe: Together, these
EVENTS
Be informed and stay informed on all
news, events and publication updated.
